| Literature DB >> 27759429 |
Sa Liu1, Yulong Chen2, Shiping Xie1, Qianlei Xu3, Jianshe Chen4, Changhai Wang5, Zhao Wang6, Suna Ma7, Xingwei Wu7, Ning Zhang8.
Abstract
OBJECTIVES: Traditional Chinese Medicine (TCM) applied in the clinic as a complementary and alternative therapy has helped improve immunity and reduce side effects and symptomatic treatment in patients with HIV/AIDS. However, the mechanisms of TCM syndromes are not clear. Transcriptomics enables the study of such TCM syndromes.Entities:
Keywords: AIDS; HIV; TCM syndromes; dampness-heat retention syndrome; differentially expressed genes; qi-yin deficiency syndrome
Mesh:
Year: 2016 PMID: 27759429 PMCID: PMC5116685 DOI: 10.1089/acm.2015.0350
Source DB: PubMed Journal: J Altern Complement Med ISSN: 1075-5535 Impact factor: 2.579
Sex Distribution Between Groups
| Case group ( | 17 | 12 | 29 |
| Control group ( | 10 | 10 | 20 |
Chi-square = 0.356; p = 0.551.
Age Distribution Between Groups
| Case group | 29 | 47.95 ± 6.51 |
| Control group | 20 | 47.25 ± 8.13 |
Means are expressed with standard deviation. t = 0.382; p = 0.703.

Different messenger RNAs (mRNAs) of the two syndromes (qi-yin deficiency and dampness-heat retention).
Predicted and Classified of Differential Genes in the Two Traditional Chinese Medicine Syndrome Groups
| t- | ||||
|---|---|---|---|---|
| 1 | 0.006712 | −2.946 | 0.64 | |
| 2 | 0.006805 | 2.94 | 1.53 | |
| 3 | 0.006365 | 2.968 | 1.61 | |
| 4 | 0.004938 | 3.072 | 2.42 | |
| 5 | 0.004692 | 3.093 | 2.26 | |
| 6 | 0.003681 | 3.191 | 1.64 | |
| 7 | 0.002231 | 3.392 | 4.52 |
Differentially expressed genes in either group were predicted and classified according to the significance level of p < 0.05, fold change ≥ 1.5. The accuracy of compound covariate predictor was 86%; accuracy of diagonal linear discriminant analysis was 93%; accuracy of three nearest neighbors was 79%; accuracy of nearest centroid was 93%, accuracy of the support vector machines was 93%; and accuracy of the Bayesian compound covariate predictor was 96%.

Upregulated and downregulated mRNAs in both differential syndromes were analyzed by using DAVID tools. After the results of the functional annotation clustering were obtained, a bar chart was drawn with the enrichment score (y-axis) and function (x-axis). Differentially expressed genes that were relevant to the function with a greater enrichment score had a greater role in disease progression and syndrome formation in HIV. Functional annotation of upregulated and downregulated mRNAs in qi-yin deficiency syndrome was showed, respectively, in (a) and (b). Functional annotation of upregulated and downregulated mRNAs was showed, respectively, in (c) and (d).
Signaling Pathways of Different Messenger RNAs of the
| p | |||||
|---|---|---|---|---|---|
| KEGG | hsa04062: Chemokine signaling pathway | 9 | 0.87 | 1.93E-04 | |
| KEGG | hsa04060: Cytokine-cytokine receptor interaction | 9 | 0.87 | 0.001822 | |
| KEGG | hsa04621: NOD-like receptor signaling pathway | 5 | 0.48 | 0.002054 | |
| KEGG | hsa04210: Apoptosis | 4 | 0.38 | 0.040987 | |
| KEGG | hsa04620: Toll-like receptor signaling pathway | 4 | 0.38 | 0.059209 | |
| KEGG | hsa04010: MAPK signaling pathway | 6 | 0.58 | 0.084914 | |
| BioCarta | h_nthiPathway: NFκB activation by nontypeable | 4 | 0.38 | 0.003331 | |
| BioCarta | h_cd40Pathway: CD40L signaling pathway | 3 | 0.29 | 0.013717 | |
| BioCarta | h_tnfr2Pathway: TNFR2 signaling pathway | 3 | 0.29 | 0.020021 | |
| BioCarta | h_deathPathway: Induction of apoptosis through DR3 and DR4/5 death receptors | 3 | 0.29 | 0.057829 | |
| BioCarta | h_il2rbPathway: IL-2 receptor β chain in T cell activation | 3 | 0.29 | 0.068567 |
Signal pathways of differential genes in both syndromes were analyzed with DAVID tools (http://david. abcc.ncifcrf.gov/). Both syndromes had the same and specific signals. Both the differentially expressed genes and the statistical p-values of both Traditional Chinese Medicine syndromes were different in terms of the common signaling pathways.
KEGG, Kyoto Encyclopedia of Genes and Genomes; NOD, nucleotide oligomerization domain; MAPK, mitogen-activated protein kinase; NFκB, nuclear factor κB; TNFR2, tumor necrosis factor receptor 2; DR, death receptor; IL-2, interleukin-2.
Signaling Pathways of Different Messenger RNAs of the Dampness-Heat Retention Syndrome
| p | |||||
|---|---|---|---|---|---|
| KEGG | hsa04621: NOD-like receptor signaling pathway | 6 | 0.84 | 4.18E-05 | |
| KEGG | hsa04620: Toll-like receptor signaling pathway | 5 | 0.70 | 0.003855 | |
| KEGG | hsa04062: Chemokine signaling pathway | 6 | 0.84 | 0.006544 | |
| KEGG | hsa04060: Cytokine-cytokine receptor interaction | 6 | 0.84 | 0.025379 | |
| KEGG | hsa04623: Cytosolic DNA-sensing pathway | 3 | 0.42 | 0.048982 | |
| KEGG | hsa05120: Epithelial cell signaling in | 3 | 0.42 | 0.071348 | |
| BioCarta | h_nthiPathway: NFκB activation by nontypeable | 4 | 0.56 | 0.00239 | |
| BioCarta | h_Ccr5Pathway: Pertussis toxin–insensitive CCR5 signaling in macrophage | 3 | 0.42 | 0.011031 | |
| BioCarta | h_cd40Pathway: CD40L signaling pathway | 3 | 0.42 | 0.011031 | |
| BioCarta | h_tnfr2Pathway: TNFR2 signaling pathway | 3 | 0.42 | 0.016146 | |
| BioCarta | h_il2rbPathway: IL-2 receptor β chain in T cell activation | 3 | 0.42 | 0.056103 |
Signal pathways of differential genes in both syndromes were analyzed with DAVID tools (http://david. abcc.ncifcrf.gov/). Both syndromes had the same and specific signals. Both the differentially expressed genes and the statistical p-values of both Traditional Chinese Medicine syndromes were different in terms of the common signaling pathways.

Pathways of differentially expressed mRNAs in qi-yin deficiency syndrome (a) and dampness-heat retention syndrome (b) were obtained through DAVID tools. Bar charts were constructed, with the p-value displayed on the x-axis and the specific pathway on the y-axis. Pathway-related differential genes with lower p-values had a greater role in disease progression and syndrome formation seen in HIV/AIDS.

With the BRB-Array Tools version 4.2 software, differentially expressed signals of the healthy control group and the syndrome groups were analyzed. Upregulated genes are shown in red and downregulated genes are displayed in green. From the image, it can be appreciated that the genetic expression in the healthy group and the disease groups was clearly different according to the color map. Partial differences in genetic expression for both syndrome groups could also be manifested in the cluster analysis image. Color images available online at www.liebertpub.com/acm

Differential mRNAs of both syndromes were loaded into STRING. Required confidence (score) was 0.70, and interactors shown were no greater than 5. Differentially expressed mRNAs, which were closely related to each other, 56 mRNAs were found in the qi-yin deficiency syndrome (a), while 32 mRNAs were found in the dampness-heat retention syndrome (b). Lines in the diagram represent the relations between gene functions, whose intimacy level was represented by the length of the line. Color images available online at www.liebertpub.com/acm
Scores of the Traditional Chinese Medicine Syndrome Before and After Treatment
| t | p | ||||
|---|---|---|---|---|---|
| 12 | 32.42 ± 10.30 | 13.18 ± 2.56 | 4.859 | 0.0001 | |
| Dampness-heat retention syndrome | 17 | 29.47 ± 6.51 | 10.46 ± 6.54 | 7.909 | 0.0001 |
Values expressed with a plus/minus sign are means ± standard deviation.
TCM, Traditional Chinese Medicine.
Immune Indices Before and After TCM Treatment
| Qi-yin | ||||
|---|---|---|---|---|
| CD4+ count (cells/mm3) | 349 ± 172 | 389 ± 264 | 372 ± 105 | 386 ± 152 |
| CD8+ count (cells/mm3) | 641 ± 199 | 985 ± 477[ | 761 ± 245 | 896 ± 274 |
| CD8+ CD28+/CD8+ (%) | 39.19 ± 13.09 | 62.17 ± 16.22[ | 34.09 ± 8.04 | 57.85 ± 12.98[ |
| CD8+ CD38+/CD8+ (%) | 48.90 ± 16.40 | 38.29 ± 14.07 | 57.62 ± 20.20 | 40.88 ± 13.36[ |
| CD4+ CD45+RA/CD4+ (%) | 32.19 ± 12.07 | 31.87 ± 9.73 | 26.91 ± 14.52 | 22.68 ± 12.32 |
| CD4+ CD45+RO/CD4+ (%) | 62.39 ± 10.21 | 57.10 ± 16.03 | 70.37 ± 15.36 | 59.78 ± 19.51 |
| CD4+ CD95+/CD4+ (%) | 45.59 ± 16.36 | 61.25 ± 20.25[ | 46.05 ± 16.35 | 60.59 ± 18.56[ |
| CD4+ CD28+/CD4+ (%) | 71.25 ± 16.08 | 53.79 ± 23.90 | 61.05 ± 21.61 | 64.36 ± 22.07 |
| CD4+ CD25+/CD4+ (%) | 14.46 ± 8.90 | 17.57 ± 11.38 | 8.71 ± 3.74 | 11.06 ± 4.68 |
| CD3−CD16+56+/Lym (%) | 16.84 ± 10.72 | 17.84 ± 10.85 | 16.64 ± 8.83 | 17.71 ± 8.02 |
The differences in the immune indices before and after TCM treatment were analyzed and compared. After receipt of medicine, CD8+CD28+ T cells and CD4+CD95+ T cells increased significantly in both syndrome groups (p < 0.05–0.01). The absolute value of CD8+ T cells increased significantly in the qi-yin deficiency syndrome group (p < 0.05) and the CD8+CD38+ T cells were reduced sharply in the dampness-heat retention syndrome group (p < 0.01). There were no significant changes in other indices (p > 0.05).
p < 0.05 for comparison of before and after TCM treatment.
p < 0.01 for comparison of before and after TCM treatment.
Eighteen Genetic Expressions Close to the Healthy Control Group in HIV/AIDS Patients, Normalized
| 230333_at | – | 0.6658 | 0.314186 | 2.0196 |
| 236495_at | – | 0.6002 | 0.260687 | 2.2371 |
| 243296_at | 0.5341 | 0.237821 | 2.1741 | |
| 243509_at | – | 0.5337 | 0.236277 | 2.1398 |
| 205681_at | 0.4042 | 0.22675 | 1.7128 | |
| 201502_s_at | 0.3995 | 0.159954 | 2.3892 | |
| 223217_s_at | 0.3825 | 0.180093 | 1.9869 | |
| 223218_s_at | 0.3218 | 0.194865 | 1.5828 | |
| 204748_at | 0.3175 | 0.113928 | 2.6392 | |
| 213524_s_at | 0.1948 | 0.022876 | 7.1192 | |
| 202859_x_at | 0.1694 | 0.035374 | 4.6883 | |
| 212130_x_at | 0.6739 | 0.435402 | 1.5164 | |
| 212227_x_at | 0.6885 | 0.446181 | 1.5024 | |
| 230529_at | 0.7672 | 0.493156 | 1.537 | |
| 201531_at | 0.7496 | 0.462924 | 1.6302 | |
| 239757_at | 0.7987 | 0.468069 | 1.6562 | |
| 204285_s_at | 0.7278 | 0.385722 | 1.8355 | |
| 212341_at | 1.245 | 0.64449 | 1.8954 |
Pathway of Genetic Expressions Close to the Healthy Control Group in HIV/AIDS Patients, Normalized
| p | q | |||
|---|---|---|---|---|
| Epithelial cell signaling in | 2 | 1.50E-04 | 9.09E-05 | |
| Small-cell lung cancer | 2 | 2.27E-04 | 9.09E-05 | |
| Toll-like receptor signaling pathway | 2 | 3.19E-04 | 1.06E-04 | |
| Nicotinate and nicotinamide metabolism | 1 | 0.00627 | 2.70E-04 | |
| Bladder cancer | 1 | 0.010949 | 4.13E-04 | |
| Arachidonic acid metabolism | 1 | 0.014833 | 5.20E-04 | |
| Adipocytokine signaling pathway | 1 | 0.017414 | 6.00E-04 | |
| p53 signaling pathway | 1 | 0.017929 | 6.03E-04 | |
| B cell receptor signaling pathway | 1 | 0.019474 | 6.25E-04 | |
| Chronic myeloid leukemia | 1 | 0.019474 | 6.25E-04 | |
| VEGF signaling pathway | 1 | 0.019732 | 6.25E-04 | |
| Prostate cancer | 1 | 0.022814 | 6.89E-04 | |
| Apoptosis | 1 | 0.023071 | 6.89E-04 | |
| T cell receptor signaling pathway | 1 | 0.028188 | 7.27E-04 | |
| Cytokine-cytokine receptor interaction | 1 | 0.066526 | 0.001401 |
HIV/AIDS patients with both syndromes were considered as disease groups. The genetic expression profiles seen before and after drug intervention were compared. After intervention, the degree of expression of 18 differentially expressed genes progressed toward the healthy control group. Through analysis of signaling pathways, 15 pathways, such as cellular apoptosis and inflammation, were related to normalized genes. When p < 0.05, there were 14 signaling pathways related to normalized genes.
VEGF, vascular endothelial growth factor.
Thirty-five Genetic Expressions Close to the Healthy Control Group in the
| 206765_at | 2.1083 | 2.994986 | 0.6208 | |
| 242625_at | 2.0502 | 4.478901 | 0.6183 | |
| 202270_at | 1.574 | 2.77847 | 0.6169 | |
| 214329_x_at | 1.5426 | 2.806688 | 0.6211 | |
| 228071_at | 1.5416 | 2.744963 | 0.566 | |
| 203761_at | 1.2939 | 2.065447 | 0.6 | |
| 219243_at | 1.362 | 2.025492 | 0.6612 | |
| 209112_at | 0.7699 | 1.533911 | 0.49 | |
| 203455_s_at | 0.6496 | 0.414196 | 1.7452 | |
| 210592_s_at | 0.6478 | 0.395959 | 1.7694 | |
| 236495_at | 0.6052 | 0.204204 | 2.1291 | |
| 201041_s_at | 0.5901 | 0.178339 | 3.3486 | |
| 225557_at | 0.5773 | 0.399585 | 1.5136 | |
| 211998_at | 0.5082 | 0.308164 | 1.8047 | |
| 214211_at | 0.4948 | 0.303608 | 1.562 | |
| 243296_at | 0.4463 | 0.22214 | 2.0051 | |
| 243509_at | 0.4416 | 0.202034 | 2.2336 | |
| 205681_at | 0.3947 | 0.217273 | 1.9054 | |
| 201502_s_at | 0.3884 | 0.160713 | 2.451 | |
| 204748_at | 0.3686 | 0.102077 | 3.5925 | |
| 204470_at | 0.3623 | 0.208837 | 1.5576 | |
| 223217_s_at | 0.3587 | 0.169925 | 2.1394 | |
| 223218_s_at | 0.3464 | 0.189468 | 2.0542 | |
| 205114_s_at | 0.2607 | 0.162641 | 1.9618 | |
| 213524_s_at | 0.224 | 0.017729 | 12.0734 | |
| 202859_x_at | 0.166 | 0.030291 | 5.7922 | |
| 201473_at | 0.8657 | 0.489024 | 1.7308 | |
| 220046_s_at | 0.7697 | 0.502441 | 1.7463 | |
| 230529_at | 0.7359 | 0.446418 | 1.6649 | |
| 202081_at | 0.6942 | 0.469971 | 1.5566 | |
| 201531_at | 0.7612 | 0.411515 | 1.8872 | |
| 239757_at | 0.7993 | 0.42851 | 1.9121 | |
| 204285_s_at | 0.7395 | 0.404904 | 1.9356 | |
| 1555411_a_at | 0.7678 | 0.486916 | 1.5989 | |
| 200844_s_at | 1.5956 | 0.638738 | 1.9763 |
Pathway of Genetic Expression Close to the Healthy Control Group in the
| p | q | |||
|---|---|---|---|---|
| Epithelial cell signaling in | 3 | 1.64E-05 | 4.11E-06 | |
| Small-cell lung cancer | 3 | 3.05E-05 | 6.03E-06 | |
| Cytokine-cytokine receptor interaction | 4 | 3.32E-05 | 6.03E-06 | |
| Toll-like receptor signaling pathway | 3 | 5.07E-05 | 6.76E-06 | |
| Systemic lupus erythematosus | 3 | 1.41E-04 | 1.28E-05 | |
| Chronic myeloid leukemia | 2 | 0.001271 | 7.48E-05 | |
| Prostate cancer | 2 | 0.001743 | 9.90E-05 | |
| Apoptosis | 2 | 0.001783 | 9.90E-05 |
Gene expression in HIV/AIDS patients with the qi-yin deficiency syndrome before and after intervention was compared. After intervention, 35 differentially expressed genes that involved eight signaling pathways progressed toward the healthy control group (p < 0.05). Compared with the results seen in the dampness-heat retention group, both syndromes had both similar and different pathways, and normalized genes that were present in both syndromes were not all the same.
Twenty-five Genetic Expression Close to the Healthy Control Group in the Dampness-Heat Retention Group
| 213524_s_at | 0.2021 | 0.024449 | 6.1832 | |
| 202859_x_at | 0.1932 | 0.036015 | 4.7861 | |
| 201502_s_at | 0.4464 | 0.162281 | 2.6321 | |
| 243296_at | 0.6436 | 0.230006 | 2.5917 | |
| 204748_at | 0.3259 | 0.115045 | 2.5699 | |
| 223217_s_at | 0.4537 | 0.176858 | 2.2493 | |
| 243509_at | – | 0.619 | 0.253299 | 2.2321 |
| 201041_s_at | 0.6134 | 0.280119 | 2.1092 | |
| 205681_at | 0.4517 | 0.208313 | 2.0323 | |
| 223218_s_at | 0.4019 | 0.190931 | 1.7416 | |
| 230333_at | – | 0.6397 | 0.310985 | 1.6559 |
| 211998_at | 0.5456 | 0.317318 | 1.6488 | |
| 210592_s_at | 0.63 | 0.393698 | 1.5412 | |
| 236495_at | – | 0.6729 | 0.258998 | 2.8924 |
| 232304_at | 0.7174 | 0.396169 | 1.8565 | |
| 212341_at | 1.3195 | 0.663453 | 1.8313 | |
| 230529_at | 0.8578 | 0.520437 | 1.6856 | |
| 201531_at | 0.8175 | 0.490776 | 1.5987 | |
| 241133_at | 0.7664 | 0.485686 | 1.592 | |
| 204115_at | 0.8588 | 0.565384 | 1.5907 | |
| 212130_x_at | 0.6802 | 0.422807 | 1.5785 | |
| 204838_s_at | 0.7652 | 0.472423 | 1.5615 | |
| 202021_x_at | 0.6741 | 0.43391 | 1.5512 | |
| 212227_x_at | 0.6856 | 0.436141 | 1.5406 | |
| 217783_s_at | 0.7626 | 0.486319 | 1.5082 |
Pathways of Genetic Expression Close to the Healthy Control Group in the Dampness-Heat Retention Group
| p | q | |||
|---|---|---|---|---|
| Systemic lupus erythematosus | 3 | 3.34E-05 | 9.53E-06 | |
| Epithelial cell signaling in | 2 | 4.30E-04 | 6.61E-05 | |
| Small cell lung cancer | 2 | 6.48E-04 | 9.25E-05 | |
| Toll-like receptor signaling pathway | 2 | 9.09E-04 | 1.21E-04 | |
| Mismatch repair | 1 | 0.009997 | 3.69E-04 | |
| Nicotinate and nicotinamide metabolism | 1 | 0.010429 | 3.69E-04 | |
| Urea cycle and metabolism of amino groups | 1 | 0.012157 | 4.12E-04 | |
| Bladder cancer | 1 | 0.018183 | 5.77E-04 | |
| Arachidonic acid metabolism | 1 | 0.024601 | 7.34E-04 | |
| Adipocytokine signaling pathway | 1 | 0.028857 | 8.49E-04 | |
| B cell receptor signaling pathway | 1 | 0.032249 | 9.07E-04 | |
| Chronic myeloid leukemia | 1 | 0.032249 | 9.07E-04 | |
| VEGF signaling pathway | 1 | 0.032672 | 9.07E-04 | |
| Prostate cancer | 1 | 0.037737 | 9.91E-04 | |
| Apoptosis | 1 | 0.038158 | 9.91E-04 | |
| T cell receptor signaling pathway | 1 | 0.046541 | 0.001029 | |
| Cytokine-cytokine receptor interaction | 1 | 0.108409 | 0.001792 | |
| MAPK signaling pathway | 1 | 0.113486 | 0.00183 |
Gene expression in HIV/AIDS patients with the dampness-heat retention syndrome before and after intervention was compared. After intervention, 25 differentially expressed genes that involved 16 signaling pathways progressed toward the healthy control group (p < 0.05). Compared with the results seen in the qi-yin deficiency syndrome group, both syndromes had both similar and different pathways, and normalized genes that were present in both syndromes were not all the same.

With BRB-Array Tools version 4.2, mRNAs in both syndromes before and after treatment and in the healthy group were analyzed by hierarchical clustering. Red represents the increase in genetic expression levels, while green represents a decrease in expression. In the qi-yin deficiency syndrome (a), some samples were misclassified into the prior-treatment disease group and the normal control group by following the intervention. Misclassification into prior treatment, post-treatment, and normal samples was also found in the dampness-heat retention group (b). After treatment, both syndrome groups were closer to the control group, and the expression levels of differentially expressed genes was normalized. Color images available online at www.liebertpub.com/acm
Immunologic Indices Before Treatment per Study Group
| Qi-yin | F | p | |||
|---|---|---|---|---|---|
| CD4+ count (cells/mm3) | 349 ± 172[ | 372 ± 105[ | 880 ± 290 | 5.364 | 0.002 |
| CD8+ count (cell/mm3) | 641 ± 199 | 761 ± 245[ | 508 ± 253 | 3.866 | 0.013 |
| CD8+ CD28+/CD8+ (%) | 39.19 ± 13.09 | 34.09 ± 8.04 | 39.24 ± 8.85 | 1.498 | 0.222 |
| CD8+ CD38+/CD8+ (%) | 48.90 ± 16.40[ | 57.62 ± 20.20[ | 35.93 ± 10.16 | 7.234 | <0.000 |
| CD4+ CD45+RA/CD4+ (%) | 32.19 ± 12.07 | 26.91 ± 14.52[ | 38.55 ± 12.02 | 3.058 | 0.034 |
| CD4+ CD45+RO/CD4+ (%) | 62.39 ± 10.21 | 70.37 ± 15.36 | 61.98 ± 11.73 | 1.860 | 0.144 |
| CD4+ CD95+/CD4+ (%) | 45.59 ± 16.36 | 46.05 ± 16.35 | 38.13 ± 8.62 | 1.643 | 0.187 |
| CD4+ CD28+/CD4+ (%) | 71.25 ± 16.08 | 61.05 ± 21.61[ | 77.61 ± 8.86 | 15.09 | 0.003 |
| CD4+ CD25+/CD4+ (%) | 14.46 ± 8.90 | 8.71 ± 3.74 | 11.90 ± 4.41 | 2.463 | 0.069 |
| CD3−CD16+ 56+/Lym (%) | 16.84 ± 10.72 | 16.64 ± 8.83 | 22.56 ± 11.19 | 1.986 | 0.096 |
Values expressed with a plus/minus sign are the mean ± standard deviation. SPSS 21.0 statistical software program was used to analyze relevant immune indices in different TCM syndromes. One-way analysis of variance was applied to analyze and compare the intergroup differences. To compare the differences in immune indices between groups, the least-squares difference method was selected for equal variances; the Dunnett T3 test was used for unequal variances. The results showed that when compared with values in the control group, the absolute value of CD4+ T cells in both disease groups was reduced significantly, while the frequency of CD8+CD38+ T cells increased significantly (p < 0.05–0.01). Further, compared with the control group, the qi-yin deficiency group had a significant decrease in absolute values of CD4+ and CD8+ T cells (p < 0.05–0.01), while the dampness-heat retention group had a significant increase in CD8 T cells and reduced frequency of CD4+CD45RA+ and CD4+CD28+ dual-positive T cells (p < 0.05–0.01). There were no significant difference seen between groups in CD8+CD28+ and CD4+CD45RO+ T cells, CD4+CD95+, and CD4+CD25+ T cells or the CD3−CD16+ 56+ T cells (p > 0.05).
p < 0.01 compared with healthy controls.
p < 0.05 compared with healthy controls.